Relfovetmab
Relfovetmab is an anti-NGF monoclonal antibody (mAb) [1].
Product Specifications
CAS Number
2171034-70-9
UNSPSC
12352203
Target
TNF Receptor
Type
Inhibitory Antibodies
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/relfovetmab.html
Purity
99.88
Solubility
10 mM in DMSO
Smiles
[Relfovetmab]
Molecular Weight
(147.94 kDa)
References & Citations
[1]Liu Wenshe Ray, et al. Protease switch for dual targets chimeric antigen receptor T-cell therapy. Patent. WO2021087245.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Isoform
TNFRSF16/NGF Receptor/CD271
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC040977-500 1x 500 µL
TGF-beta (1D11.16.8), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740218-500 1x 500 µL
CD100 (Semaphorin-4D) (A8), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC741429-100 1x 100 µL
E-Cadherin / CD324 (Intercellular Junction Marker) (4A2), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940026-500 1x 500 µL
ACTH (Adrenocorticotrophic Hormone) (AH26), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details